Clinical Significance of slow recovery of graft function in living donor kidney transplantation

Transplantation

Volumn 90, Issue 1, 2010, Pages 38-43

  Lee, So Young ^a   Chung, Byung Ha ^a   Piao, Shang Guo ^a   Kang, Seok Hui ^a   Hyoung, Bok Jin ^a   Jeon, Youn Joo ^a   Hwang, Hyeon Seok ^a   Yoon, Hye Eun ^a   Choi, Bum Soon ^a   Kim, Ji Il ^a   Moon, In Sung ^a   Kim, Yong Soo ^a   Choi, Yeong Jin ^a   Yang, Chul Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Graft function; Kidney transplantation; Protocol biopsy.

Indexed keywords

COMPLEMENT COMPONENT C4D; CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CONVALESCENCE; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; GROUPS BY AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; ADULT; BIOPSY; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVORS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 77954622177     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e065a2     Document Type: Article

References (27)

1. Humar A, Johnson EM, Payne WD, et al. Effect of initial slow graft function on renal allograft rejection and survival.Clin Transplant 1997; 11: 623.
2. Park JH, Yang CW, Kim YS, et al. Comparisons of clinicopathological correlations between immediate and slow graft function in renal transplant recipients. Clin Transplant 2002; 16(suppl 8): 18.
3. Shomori K, Kuratate I, Sakatani T, et al. Histopathology of a human allografted kidney with clinically sufficient function. Clin Transplant 2000; 14(suppl 3): 25.
4. Johnston O, O'Kelly P, Spencer S, et al. Reduced graft function (with or without dialysis) vs immediate graft function\A comparison of long-term renal allograft survival. Nephrol Dial Transplant 2006; 21: 2270.
5. Pöge U, Gerhardt T, PalmedoH, et al. MDRD equations for estimation of GFR in renal transplant recipients. Am J Transplant 2005; 5: 1306.
6. Stevens LA, Levey AS. Measurement of kidney function. Med Clin North Am 2005; 89: 457.
7. Stoves J, Lindley EJ, Barnfield MC, et al. MDRD equation estimates of glomerular filtration rate in potential living kidney donors and renal transplant recipients with impaired graft function. Nephrol Dial Transplant 2002; 17: 2036.
8. Poggio ED, Wang X, Greene T, et al. Performance of the modification of dietin renal disease and Cockcroft-Gault equations inthe estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005; 16: 459.
9. Siddiqi N, McBride MA, Hariharan S. Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis. Kidney Int 2004; 65: 1906.
10. Seo SI, Kim JC, Hwangbo K, et al. Comparison of hand-assisted lapa-roscopic and open donor nephrectomy: A single-center experience from South Korea. J Endourol 2005; 19: 58.
11. Humar A, Ramcharan T, Kandaswamy R, et al. Risk factors for slow graft function after kidney transplants: A multivariate analysis. Clin Transplant 2002; 16: 425.
12. Johnson C, Ahsan N, Gonwa T, et al. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000; 69: 834.
13. Webster AC, Woodroffe RC, Taylor RS, et al. Tacrolimus versus ciclos-porin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression ofrandomised trial data.BMJ2005; 331: 810.
14. Halloran P, Mathew T, TomlanovichS, et al. Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 1997; 63: 39.
15. Kainz A, Heinze G, Korbely R, et al. Mycophenolate mofetil use is associated with prolonged graft survival after kidney transplantation. Transplantation 2009; 88: 1095.
16. Choi BS, Shin MJ, Shin SJ, et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: Ten-year experience at a single center. Am J Transplant 2005; 5: 1354.
17. Rush DN, Henry SF, Jeffery JR, et al. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994; 57: 208.
18. Howard RJ, Pfaff WW, Brunson ME, et al. Increased incidence of rejection in patients with delayed graft function. Clin Transplant 1994; 8: 527.
19. Moreso F, Ibernon M, Goma M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747.
20. GiralM, Nguyen JM, KaramG, et al. Impactofgraft massonthe clinical outcome of kidney transplants. J Am Soc Nephrol 2005; 16: 261.
21. el-Agroudy AE, Hassan NA, Bakr MA, et al. Effect of donor/recipient body weight mismatch on patient and graft outcome in living-donor kidney transplantation. Am J Nephrol 2003; 23: 294.
22. Nicholson ML, Windmill DC, Horsburgh T, et al. Influence of allograft size to recipient body-weight ratio on the long-term outcome of renal transplantation. Br J Surg 2000; 87: 314.
23. Quarto di Palo F, Rivolta R, Elli A, et al. The transplanted nephronic mass influences renal vascular resistance and blood flow of the kidney graft. Nephron 1997; 76: 43.
24. Douverny JB, Baptista-Silva JC, Pestana JO, et al. Importance of renal mass ongraft function outcome after 12 months ofliving donor kidney transplantation. Nephrol Dial Transplant 2007; 22: 3646.
25. Rush D, Nickerson P, Gough J, et al. Beneficial effects of treatment of early subclinical rejection: Arandomized study. J Am Soc Nephrol 1998; 9: 2129.
26. Humar A, Kerr S, Gillingham KJ, et al. Features of acute rejection that increase risk for chronic rejection. Transplantation 1999; 68: 1200.
27. Halloran PF, Aprile MA, Farewell V, et al. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated witha protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 1988; 46: 223.